These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


324 related items for PubMed ID: 23759507

  • 1. Evaluation of the effect of oritavancin on Clostridium difficile spore germination, outgrowth and recovery.
    Chilton CH, Freeman J, Baines SD, Crowther GS, Nicholson S, Wilcox MH.
    J Antimicrob Chemother; 2013 Sep; 68(9):2078-82. PubMed ID: 23759507
    [Abstract] [Full Text] [Related]

  • 2. Oritavancin does not induce Clostridium difficile germination and toxin production in hamsters or a human gut model.
    Freeman J, Marquis M, Crowther GS, Todhunter SL, Fawley WN, Chilton CH, Moeck G, Lehoux D, Wilcox MH.
    J Antimicrob Chemother; 2012 Dec; 67(12):2919-26. PubMed ID: 22899803
    [Abstract] [Full Text] [Related]

  • 3. Comparison of oritavancin versus vancomycin as treatments for clindamycin-induced Clostridium difficile PCR ribotype 027 infection in a human gut model.
    Baines SD, O'Connor R, Saxton K, Freeman J, Wilcox MH.
    J Antimicrob Chemother; 2008 Nov; 62(5):1078-85. PubMed ID: 18772161
    [Abstract] [Full Text] [Related]

  • 4. Association of Fidaxomicin with C. difficile Spores: Effects of Persistence on Subsequent Spore Recovery, Outgrowth and Toxin Production.
    Chilton CH, Crowther GS, Ashwin H, Longshaw CM, Wilcox MH.
    PLoS One; 2016 Nov; 11(8):e0161200. PubMed ID: 27556739
    [Abstract] [Full Text] [Related]

  • 5. Activity of vancomycin against epidemic Clostridium difficile strains in a human gut model.
    Baines SD, O'Connor R, Saxton K, Freeman J, Wilcox MH.
    J Antimicrob Chemother; 2009 Mar; 63(3):520-5. PubMed ID: 19112083
    [Abstract] [Full Text] [Related]

  • 6. Effectiveness of a short (4 day) course of oritavancin in the treatment of simulated Clostridium difficile infection using a human gut model.
    Chilton CH, Freeman J, Crowther GS, Todhunter SL, Wilcox MH.
    J Antimicrob Chemother; 2012 Oct; 67(10):2434-7. PubMed ID: 22723601
    [Abstract] [Full Text] [Related]

  • 7. In vitro susceptibility of genotypically distinct and clonal Clostridium difficile strains to oritavancin.
    O'Connor R, Baines SD, Freeman J, Wilcox MH.
    J Antimicrob Chemother; 2008 Oct; 62(4):762-5. PubMed ID: 18606787
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. In vitro efficacy of sodium selenite in reducing toxin production, spore outgrowth and antibiotic resistance in hypervirulent Clostridium difficile.
    Pellissery AJ, Vinayamohan PG, Yin HB, Mooyottu S, Venkitanarayanan K.
    J Med Microbiol; 2019 Jul; 68(7):1118-1128. PubMed ID: 31172910
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Germination efficiency of clinical Clostridium difficile spores and correlation with ribotype, disease severity and therapy failure.
    Moore P, Kyne L, Martin A, Solomon K.
    J Med Microbiol; 2013 Sep; 62(Pt 9):1405-1413. PubMed ID: 23518657
    [Abstract] [Full Text] [Related]

  • 12. Antibacterial activity of rhodomyrtone on Clostridium difficile vegetative cells and spores in vitro.
    Srisuwan S, Mackin KE, Hocking D, Lyras D, Bennett-Wood V, Voravuthikunchai SP, Robins-Browne RM.
    Int J Antimicrob Agents; 2018 Nov; 52(5):724-729. PubMed ID: 30145248
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Investigating the effect of supplementation on Clostridioides (Clostridium) difficile spore recovery in two solid agars.
    Pickering DS, Vernon JJ, Freeman J, Wilcox MH, Chilton CH.
    Anaerobe; 2018 Apr; 50():38-43. PubMed ID: 29408598
    [Abstract] [Full Text] [Related]

  • 18. The effect of hospital biocide sodium dichloroisocyanurate on the viability and properties of Clostridium difficile spores.
    Joshi LT, Welsch A, Hawkins J, Baillie L.
    Lett Appl Microbiol; 2017 Sep; 65(3):199-205. PubMed ID: 28639362
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.